Balance Sheet Fortive Corporation

Equities

FTV

US34959J1088

Industrial Machinery & Equipment

Market Closed - Nyse Other stock markets 02:30:02 22/01/2026 am IST			5-day change	1st Jan Change
54.44 ^USD	+3.30%		-2.37%	-1.39%

16/01	JPMorgan Downgrades Fortive to Underweight From Neutral, Adjusts Price Target to $57 From $55	MT
15/01	Advanced Sterilization Products (ASP) announces CE mark for Ultra Gi(TM) cycle for duodenoscopes in partnership with Fujifilm Healthcare Europe	RE

2b8127.ZWZWmMKlZzbo7fDH5yWkbX6HmiH-fAkUQ-I86LWR14s.Bjws-6_MEF6ZhpeShG7eJSfW8m6vGjhTcNN73Nb4vLJREh6178kiRomItQ

Published financial data: FORTIVE CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	463.44Cr	525.47Cr	582.57Cr	606.53Cr	623.18Cr
Total Revenues	463.44Cr	525.47Cr	582.57Cr	606.53Cr	623.18Cr
Cost of Goods Sold, Total	201.77Cr	224.48Cr	246.23Cr	247.12Cr	250.08Cr
Gross Profit	261.67Cr	300.99Cr	336.34Cr	359.41Cr	373.1Cr
Selling General & Admin Expenses, Total	166.22Cr	176.69Cr	193.54Cr	206.55Cr	217.41Cr
R&D Expenses	32Cr	35Cr	40Cr	40Cr	41Cr
Other Operating Expenses, Total	198.29Cr	212.17Cr	233.69Cr	246.33Cr	258.81Cr
Operating Income	63Cr	89Cr	102.65Cr	113.08Cr	114.29Cr
Interest Expense, Total	-15Cr	-10Cr	-9.83Cr	-12Cr	-15Cr
Net Interest Expenses	-15Cr	-10Cr	-9.83Cr	-12Cr	-15Cr
Income (Loss) On Equity Invest.	-40L	-1.1Cr	-	-	-
Other Non Operating Income (Expenses)	40L	-9L	-1.6Cr	-1.65Cr	-5.8Cr
EBT, Excl. Unusual Items	49Cr	77Cr	91Cr	99Cr	93Cr
Restructuring Charges	-2.68Cr	-1.87Cr	-1.79Cr	-	-
Merger & Related Restructuring Charges	-7Cr	-5.89Cr	-2.08Cr	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	111.92Cr	5.7Cr	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	3.75Cr
Legal Settlements	-	2.99Cr	-	-	-
Other Unusual Items	-	-10Cr	-	-	-
EBT, Incl. Unusual Items	150.77Cr	68Cr	87Cr	99Cr	97Cr
Income Tax Expense	5.55Cr	6.33Cr	12Cr	12Cr	14Cr
Earnings From Continuing Operations	145.22Cr	61Cr	76Cr	87Cr	83Cr
Earnings Of Discontinued Operations	16Cr	-58L	-	-	-
Net Income to Company	161.33Cr	61Cr	76Cr	87Cr	83Cr
Net Income - (IS)	161.33Cr	61Cr	76Cr	87Cr	83Cr
Preferred Dividend and Other Adjustments	6.9Cr	3.45Cr	-	-	-
Net Income to Common Incl Extra Items	154.43Cr	57Cr	76Cr	87Cr	83Cr
Net Income to Common Excl. Extra Items	138.32Cr	58Cr	76Cr	87Cr	83Cr
Per Share Items
Net EPS - Basic	4.58	1.64	2.12	2.46	2.39
Basic EPS - Continuing Operations	4.1	1.66	2.12	2.46	2.39
Basic Weighted Average Shares Outstanding	34Cr	35Cr	36Cr	35Cr	35Cr
Net EPS - Diluted	4.49	1.63	2.1	2.43	2.36
Diluted EPS - Continuing Operations	4.05	1.65	2.1	2.43	2.36
Diluted Weighted Average Shares Outstanding	36Cr	35Cr	36Cr	36Cr	35Cr
Normalized Basic EPS	0.9	1.38	1.6	1.76	1.67
Normalized Diluted EPS	0.84	1.37	1.58	1.74	1.65
Dividend Per Share	0.28	0.28	0.28	0.29	0.32
Payout Ratio	10.13	21.73	13.18	11.78	13.35
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	101.78Cr	128.37Cr	149.21Cr	158.76Cr	168.68Cr
EBITA	94Cr	120.9Cr	140.86Cr	150.12Cr	159.62Cr
EBIT	63Cr	89Cr	102.65Cr	113.08Cr	114.29Cr
EBITDAR	107.78Cr	134.37Cr	154.81Cr	163.66Cr	173.78Cr
Total Revenues (As Reported)	463.44Cr	525.47Cr	582.57Cr	606.53Cr	623.18Cr
Effective Tax Rate - (Ratio)	3.68	9.34	13.54	12.62	14.1
Current Domestic Taxes	7.88Cr	2.93Cr	9.51Cr	13Cr	6.34Cr
Current Foreign Taxes	7.43Cr	7.5Cr	8.53Cr	9.73Cr	14Cr
Total Current Taxes	15Cr	10Cr	18Cr	23Cr	20Cr
Deferred Domestic Taxes	-6.46Cr	-2.41Cr	-7.07Cr	-8.08Cr	-5.3Cr
Deferred Foreign Taxes	-3.3Cr	-1.69Cr	86L	-2.33Cr	-1.2Cr
Total Deferred Taxes	-9.76Cr	-4.1Cr	-6.21Cr	-10Cr	-6.5Cr
Normalized Net Income	30Cr	48Cr	57Cr	62Cr	58Cr
Interest on Long-Term Debt	5.4Cr	4.5Cr	21L	-	-
Non-Cash Pension Expense	24L	22L	-4L	29L	6L
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	32Cr	35Cr	40Cr	40Cr	41Cr
Net Rental Expense, Total	6Cr	6Cr	5.6Cr	4.9Cr	5.1Cr
Imputed Operating Lease Interest Expense	1.3Cr	1.16Cr	1.16Cr	1.34Cr	1.62Cr
Imputed Operating Lease Depreciation	4.7Cr	4.84Cr	4.44Cr	3.56Cr	3.48Cr
Stock-Based Comp., SG&A Exp. (Total)	6.26Cr	7.74Cr	9.38Cr	11Cr	11Cr
Total Stock-Based Compensation	6.26Cr	7.74Cr	9.38Cr	11Cr	11Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	182.48Cr	82Cr	71Cr	188.88Cr	81Cr
Short Term Investments	111.92Cr	-	-	-	-
Total Cash And Short Term Investments	294.4Cr	82Cr	71Cr	188.88Cr	81Cr
Accounts Receivable, Total	81Cr	93Cr	96Cr	106.88Cr	106.34Cr
Total Receivables	81Cr	93Cr	96Cr	106.88Cr	106.34Cr
Inventory	46Cr	51Cr	54Cr	54Cr	54Cr
Prepaid Expenses	21Cr	25Cr	27Cr	18Cr	17Cr
Other Current Assets, Total	3.04Cr	-	-	-	-
Total Current Assets	444.69Cr	251.49Cr	247.7Cr	367.16Cr	259.23Cr
Gross Property Plant And Equipment	128.52Cr	125.01Cr	133.84Cr	140.38Cr	142.57Cr
Accumulated Depreciation	-67Cr	-68Cr	-75Cr	-81Cr	-83Cr
Net Property Plant And Equipment	61Cr	57Cr	58Cr	59Cr	60Cr
Long-term Investments	7.7Cr	-	-	-	-
Goodwill	735.92Cr	915.2Cr	904.85Cr	912.17Cr	1.02TCr
Other Intangibles, Total	329.06Cr	389.02Cr	348.74Cr	315.98Cr	334Cr
Deferred Tax Assets Long-Term	27Cr	-	-	-	-
Other Long-Term Assets, Total	12L	34Cr	29Cr	36Cr	33Cr
Total Assets	1.61TCr	1.65TCr	1.59TCr	1.69TCr	1.7TCr
Liabilities
Accounts Payable, Total	48Cr	56Cr	62Cr	61Cr	68Cr
Accrued Expenses, Total	29Cr	28Cr	27Cr	30Cr	27Cr
Current Portion of Long-Term Debt	139.98Cr	215.17Cr	100Cr	-	38Cr
Current Portion of Leases	4.7Cr	4.46Cr	3.84Cr	3.76Cr	3.68Cr
Current Income Taxes Payable	6.55Cr	5.3Cr	13Cr	13Cr	15Cr
Unearned Revenue Current, Total	38Cr	46Cr	51Cr	54Cr	55Cr
Other Current Liabilities	20Cr	17Cr	16Cr	17Cr	18Cr
Total Current Liabilities	286.08Cr	371.49Cr	272.71Cr	179.13Cr	223.84Cr
Long-Term Debt	283.03Cr	180.73Cr	225.16Cr	364.62Cr	333.11Cr
Long-Term Leases	15Cr	14Cr	13Cr	13Cr	13Cr
Unearned Revenue Non Current	3.42Cr	3.38Cr	3.8Cr	4.58Cr	5.89Cr
Pension & Other Post Retirement Benefits	17Cr	13Cr	7.79Cr	8.87Cr	8.07Cr
Other Non Current Liabilities	103.21Cr	111.87Cr	98Cr	89Cr	98Cr
Total Liabilities	707.88Cr	694.85Cr	620.2Cr	658.65Cr	682.05Cr
Common Stock, Total	34L	36L	36L	36L	37L
Additional Paid In Capital	355.45Cr	367Cr	370.63Cr	385.13Cr	403.5Cr
Retained Earnings	554.74Cr	602.36Cr	674.21Cr	750.59Cr	822.76Cr
Treasury Stock	-	-	-44Cr	-72Cr	-161.23Cr
Comprehensive Income and Other	-14Cr	-18Cr	-33Cr	-33Cr	-47Cr
Total Common Equity	896.42Cr	951.22Cr	968.34Cr	1.03TCr	1.02TCr
Minority Interest	85L	48L	52L	64L	70L
Total Equity	897.27Cr	951.7Cr	968.86Cr	1.03TCr	1.02TCr
Total Liabilities And Equity	1.61TCr	1.65TCr	1.59TCr	1.69TCr	1.7TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	34Cr	36Cr	35Cr	35Cr	34Cr
ECS Total Common Shares Outstanding	34Cr	36Cr	35Cr	35Cr	34Cr
Book Value / Share	26.53	26.49	27.44	29.42	29.86
Tangible Book Value	-168.56Cr	-353Cr	-285.25Cr	-196.26Cr	-330.74Cr
Tangible Book Value Per Share	-4.99	-9.83	-8.08	-5.6	-9.69
Total Debt	443.14Cr	414.35Cr	342.07Cr	381.01Cr	387.69Cr
Net Debt	148.74Cr	332.42Cr	271.15Cr	192.13Cr	306.36Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	17Cr	13Cr	7.52Cr	8.22Cr	7.35Cr
Debt Equivalent Oper. Leases	48Cr	48Cr	45Cr	39Cr	41Cr
Minority Interest, Total (Incl. Fin. Div)	85L	48L	52L	64L	70L
Equity Method Investments, Total	7.7Cr	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	15Cr	20Cr	22Cr	21Cr	22Cr
Inventories - Work In Process, Total	7.52Cr	9.4Cr	9.64Cr	11Cr	11Cr
Inventories - Finished Goods, Total	23Cr	22Cr	22Cr	21Cr	22Cr
Land - (BS)	5.71Cr	5.49Cr	5.43Cr	5.44Cr	4.51Cr
Buildings, Total	32Cr	31Cr	31Cr	32Cr	28Cr
Machinery, Total	72Cr	71Cr	81Cr	88Cr	93Cr
Full Time Employees	17T	18T	18T	18T	18T
Accumulated Allowance for Doubtful Accounts (Supple)	4.25Cr	3.97Cr	4.39Cr	3.92Cr	3.07Cr
Order Backlog	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	161.33Cr	61Cr	76Cr	87Cr	83Cr
Depreciation & Amortization - CF	7.41Cr	7.47Cr	8.35Cr	8.64Cr	9.06Cr
Amortization of Goodwill and Intangible Assets - (CF)	31Cr	32Cr	38Cr	37Cr	45Cr
Depreciation & Amortization, Total	38Cr	40Cr	47Cr	46Cr	54Cr
(Gain) Loss From Sale Of Asset	-53L	-	-	-	-3.75Cr
(Gain) Loss on Sale of Investments - (CF)	-111.92Cr	-5.7Cr	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	-	3.94Cr
Stock-Based Compensation (CF)	6.26Cr	7.74Cr	9.38Cr	11Cr	11Cr
Net Cash From Discontinued Operations	46Cr	-3.18Cr	-	-	-
Other Operating Activities, Total	-16Cr	8.01Cr	92L	-	-
Change In Accounts Receivable	8.24Cr	-8.41Cr	-5.21Cr	98L	-45L
Change In Inventories	-73L	-5.36Cr	-4.03Cr	-17L	88L
Change In Accounts Payable	1.81Cr	7.34Cr	8.13Cr	-1.68Cr	7.43Cr
Change In Deferred Taxes	-9.76Cr	-4.1Cr	-6.21Cr	-10Cr	-6.5Cr
Change in Other Net Operating Assets	21Cr	-62L	5.26Cr	3.05Cr	2.53Cr
Cash from Operations	143.67Cr	96Cr	130.32Cr	135.36Cr	152.68Cr
Capital Expenditure	-7.57Cr	-5Cr	-9.58Cr	-11Cr	-12Cr
Sale of Property, Plant, and Equipment	53L	45L	96L	74L	6.12Cr
Cash Acquisitions	-4.04Cr	-257.01Cr	-1.28Cr	-9.58Cr	-172.18Cr
Divestitures	-	-	-	-	-1.4Cr
Sale (Purchase) of Real Estate properties	-	-	-	-	-
Other Investing Activities, Total	-3.76Cr	-	-35L	8L	-10L
Cash from Investing	-15Cr	-261.56Cr	-10Cr	-20Cr	-179.6Cr
Short Term Debt Issued, Total	-	36Cr	3.85Cr	84Cr	-
Long-Term Debt Issued, Total	75Cr	100.01Cr	139.41Cr	55Cr	173.35Cr
Total Debt Issued	75Cr	136.5Cr	143.26Cr	138.92Cr	173.35Cr
Short Term Debt Repaid, Total	-114.19Cr	-	-	-	-60Cr
Long-Term Debt Repaid, Total	-173.08Cr	-61Cr	-215.65Cr	-100Cr	-100Cr
Total Debt Repaid	-287.27Cr	-61Cr	-215.65Cr	-100Cr	-159.65Cr
Repurchase of Common Stock	-	-	-44Cr	-27Cr	-89Cr
Issuance of Preferred Stock	-	-	-	-	-
Common Dividends Paid	-9.44Cr	-9.77Cr	-9.95Cr	-10Cr	-11Cr
Preferred Dividends Paid	-6.9Cr	-3.45Cr	-	-	-
Common & Preferred Stock Dividends Paid	-16Cr	-13Cr	-9.95Cr	-10Cr	-11Cr
Other Financing Activities, Total	159.03Cr	3.03Cr	-67L	1.8Cr	7.11Cr
Cash from Financing	-70Cr	65Cr	-127.3Cr	3.23Cr	-79Cr
Foreign Exchange Rate Adjustments	2.74Cr	-30L	-3.78Cr	-1.09Cr	-1.36Cr
Net Change in Cash	62Cr	-100.55Cr	-11Cr	117.96Cr	-107.55Cr
Supplemental Items
Cash Interest Paid	12Cr	-	-	-	-
Cash Income Tax Paid (Refund)	9.5Cr	10Cr	15Cr	22Cr	22Cr
Levered Free Cash Flow	114.38Cr	83Cr	114.19Cr	114.16Cr	122.7Cr
Unlevered Free Cash Flow	123.66Cr	89Cr	120.34Cr	121.88Cr	132.25Cr
Change In Net Working Capital	-47Cr	8.81Cr	-9.82Cr	-4.97Cr	-7.55Cr
Net Debt Issued / Repaid	-212.3Cr	75Cr	-72Cr	39Cr	14Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	2.37	3.41	3.97	4.31	4.21
Return on Total Capital	2.9	4.1	4.79	5.19	5.06
Return On Equity %	17.74	6.64	7.86	8.65	8.12
Return on Common Equity	16.92	6.28	7.87	8.66	8.12
Margin Analysis
Gross Profit Margin %	56.46	57.28	57.73	59.26	59.87
SG&A Margin	35.87	33.63	33.22	34.05	34.89
EBITDA Margin %	21.96	24.43	25.61	26.18	27.07
EBITA Margin %	20.36	23.01	24.18	24.75	25.61
EBIT Margin %	13.68	16.9	17.62	18.64	18.34
Income From Continuing Operations Margin %	31.34	11.69	12.96	14.27	13.37
Net Income Margin %	34.81	11.58	12.96	14.27	13.37
Net Avail. For Common Margin %	29.85	11.03	12.96	14.27	13.37
Normalized Net Income Margin	6.54	9.2	9.79	10.21	9.35
Levered Free Cash Flow Margin	24.68	15.71	19.6	18.82	19.69
Unlevered Free Cash Flow Margin	26.68	16.94	20.66	20.09	21.22
Asset Turnover
Asset Turnover	0.28	0.32	0.36	0.37	0.37
Fixed Assets Turnover	7.75	8.89	10.09	10.29	10.46
Receivables Turnover (Average Receivables)	5.45	6.04	6.17	5.75	5.85
Inventory Turnover (Average Inventory)	4.63	4.64	4.69	4.6	4.62
Short Term Liquidity
Current Ratio	1.55	0.68	0.91	2.05	1.16
Quick Ratio	1.31	0.47	0.61	1.65	0.84
Operating Cash Flow to Current Liabilities	0.5	0.26	0.48	0.76	0.68
Days Sales Outstanding (Average Receivables)	67.17	60.45	59.17	63.47	62.61
Days Outstanding Inventory (Average Inventory)	79.06	78.71	77.78	79.29	79.15
Average Days Payable Outstanding	82.72	82.35	86.68	90.95	93.81
Cash Conversion Cycle (Average Days)	63.51	56.82	50.26	51.81	47.96
Long Term Solvency
Total Debt/Equity	49.39	43.54	35.31	36.9	38.03
Total Debt / Total Capital	33.06	30.33	26.09	26.95	27.55
LT Debt/Equity	33.26	20.46	24.59	36.54	33.97
Long-Term Debt / Total Capital	22.27	14.25	18.17	26.69	24.61
Total Liabilities / Total Assets	44.1	42.2	39.03	38.95	40.08
EBIT / Interest Expense	4.27	8.61	10.44	9.16	7.48
EBITDA / Interest Expense	7.26	13.02	15.75	13.25	11.37
(EBITDA - Capex) / Interest Expense	6.75	12.54	14.77	12.38	10.59
Total Debt / EBITDA	4.11	3.08	2.21	2.33	2.23
Net Debt / EBITDA	1.38	2.47	1.75	1.17	1.76
Total Debt / (EBITDA - Capex)	4.42	3.2	2.36	2.49	2.4
Net Debt / (EBITDA - Capex)	1.48	2.57	1.87	1.26	1.89
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.54	13.38	10.87	4.11	2.75
Gross Profit, 1 Yr. Growth %	4.79	15.03	11.74	6.86	3.81
EBITDA, 1 Yr. Growth %	8.73	26.12	21.82	7.9	6.25
EBITA, 1 Yr. Growth %	10.3	28.11	22.48	8.17	6.33
EBIT, 1 Yr. Growth %	6.59	40.14	23.78	12.44	1.07
Earnings From Cont. Operations, 1 Yr. Growth %	441.66	-57.71	22.96	14.65	-3.8
Net Income, 1 Yr. Growth %	118.34	-62.29	24.13	14.65	-3.8
Normalized Net Income, 1 Yr. Growth %	8.01	59.3	27.72	10.21	-5.92
Diluted EPS Before Extra, 1 Yr. Growth %	585.61	-59.21	27.16	15.82	-2.88
Accounts Receivable, 1 Yr. Growth %	-9.03	14.8	3.04	2.72	-0.51
Inventory, 1 Yr. Growth %	9.44	12.56	4.68	0.04	1.47
Net Property, Plant and Equip., 1 Yr. Growth %	4.39	-6.48	2.24	1.87	0.39
Total Assets, 1 Yr. Growth %	-7.96	2.58	-3.49	6.43	0.62
Tangible Book Value, 1 Yr. Growth %	-50.79	109.42	-19.19	-31.2	68.52
Common Equity, 1 Yr. Growth %	21.35	6.11	1.8	6.56	-1.26
Cash From Operations, 1 Yr. Growth %	13	-33.1	35.59	3.87	12.8
Capital Expenditures, 1 Yr. Growth %	1.61	-33.95	91.6	12.53	11.69
Levered Free Cash Flow, 1 Yr. Growth %	281.53	-27.84	44.8	1.12	7.49
Unlevered Free Cash Flow, 1 Yr. Growth %	217.96	-28.04	41.06	2.38	8.51
Dividend Per Share, 1 Yr. Growth %	0	0	0	3.57	10.34
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	10.43	7.3	12.12	7.44	3.43
Gross Profit, 2 Yr. CAGR %	9.36	9.79	13.37	9.33	5.32
EBITDA, 2 Yr. CAGR %	8.6	17.1	25.47	14.73	7.07
EBITA, 2 Yr. CAGR %	9.07	18.87	26.97	15.19	7.25
EBIT, 2 Yr. CAGR %	-4.08	22.22	34.93	18.11	6.6
Earnings From Cont. Operations, 2 Yr. CAGR %	72.12	51.36	-27.89	18.73	5.02
Net Income, 2 Yr. CAGR %	-25.59	-9.26	-31.58	19.29	5.02
Normalized Net Income, 2 Yr. CAGR %	-10.97	31.17	48.21	19.36	1.82
Diluted EPS Before Extra, 2 Yr. CAGR %	76.4	67.23	-27.98	21.36	6.06
Accounts Receivable, 2 Yr. CAGR %	-17.66	2.19	8.76	7.19	1.09
Inventory, 2 Yr. CAGR %	-10.96	10.99	8.55	2.33	0.75
Net Property, Plant and Equip., 2 Yr. CAGR %	2.96	-1.2	-2.22	2.05	1.12
Total Assets, 2 Yr. CAGR %	11.52	-2.83	-0.5	1.35	3.48
Tangible Book Value, 2 Yr. CAGR %	-8.51	1.52	30.09	-25.44	7.68
Common Equity, 2 Yr. CAGR %	16.58	13.48	3.93	4.15	2.58
Cash From Operations, 2 Yr. CAGR %	3.38	-13.06	-4.76	18.68	8.24
Capital Expenditures, 2 Yr. CAGR %	4.07	-18.08	12.5	46.83	12.11
Levered Free Cash Flow, 2 Yr. CAGR %	33.35	65.93	1.88	21.22	4.25
Unlevered Free Cash Flow, 2 Yr. CAGR %	33.73	51.27	0.44	20.35	5.4
Dividend Per Share, 2 Yr. CAGR %	0	0	0	1.77	6.9
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-6.97	11.41	8.48	9.38	5.85
Gross Profit, 3 Yr. CAGR %	-3.63	11.22	10.44	11.16	7.45
EBITDA, 3 Yr. CAGR %	-8.64	14.15	16.81	18.76	11.83
EBITA, 3 Yr. CAGR %	-8.73	15.08	18.08	19.77	12.16
EBIT, 3 Yr. CAGR %	-18.63	8.84	19.96	26.11	12.13
Earnings From Cont. Operations, 3 Yr. CAGR %	17.98	7.81	41.23	-15.84	10.69
Net Income, 3 Yr. CAGR %	15.59	-40.67	0.73	-18.74	11.04
Normalized Net Income, 3 Yr. CAGR %	-23.78	8.08	26.62	33.62	10.25
Diluted EPS Before Extra, 3 Yr. CAGR %	17.24	8.27	52.64	-15.62	12.67
Accounts Receivable, 3 Yr. CAGR %	-7.4	-8.01	2.48	9.67	4.56
Inventory, 3 Yr. CAGR %	-3.49	-3.72	8.85	5.63	2.04
Net Property, Plant and Equip., 3 Yr. CAGR %	0.02	-0.29	-0.06	-0.88	1.5
Total Assets, 3 Yr. CAGR %	15.2	8.46	-3.05	1.76	1.1
Tangible Book Value, 3 Yr. CAGR %	-5.95	20.57	-5.92	5.2	-2.15
Common Equity, 3 Yr. CAGR %	33.23	12.98	9.44	4.8	2.32
Cash From Operations, 3 Yr. CAGR %	6.89	-10.58	0.83	-1.97	16.68
Capital Expenditures, 3 Yr. CAGR %	-12	-10.57	8.74	12.51	34.04
Levered Free Cash Flow, 3 Yr. CAGR %	22.8	8.67	56.17	1.24	16.45
Unlevered Free Cash Flow, 3 Yr. CAGR %	22.47	8.77	45.72	0.72	16.27
Dividend Per Share, 3 Yr. CAGR %	0	0	0	1.18	4.55
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-5.59	-0.46	0.24	9.8	6.43
Gross Profit, 5 Yr. CAGR %	-2.74	2.26	2.84	10.44	8.36
EBITDA, 5 Yr. CAGR %	-7.1	0.73	2.26	12.97	12.5
EBITA, 5 Yr. CAGR %	-7.36	0.79	2.56	13.61	13.28
EBIT, 5 Yr. CAGR %	-13.3	-3.78	-2.69	10.42	13.96
Earnings From Cont. Operations, 5 Yr. CAGR %	10.95	-3.66	-3.11	12.05	25.45
Net Income, 5 Yr. CAGR %	13.31	-6.95	-6.28	-21.55	2.42
Normalized Net Income, 5 Yr. CAGR %	-17.81	-5.59	-3.6	10.1	15.71
Diluted EPS Before Extra, 5 Yr. CAGR %	10.1	-4.98	-3.52	13.33	31.95
Accounts Receivable, 5 Yr. CAGR %	-3.72	-0.32	-1.25	-2.21	3.61
Inventory, 5 Yr. CAGR %	-2.72	-1.2	1.16	-1.34	5.53
Net Property, Plant and Equip., 5 Yr. CAGR %	3.48	0.84	-0.88	0.64	0.41
Total Assets, 5 Yr. CAGR %	17.36	14.99	8.64	5.56	-0.49
Tangible Book Value, 5 Yr. CAGR %	29.02	11.61	7.08	-0.51	-0.7
Common Equity, 5 Yr. CAGR %	11.6	28.76	20.63	9.36	6.64
Cash From Operations, 5 Yr. CAGR %	7.32	-3.3	2.07	0.14	3.73
Capital Expenditures, 5 Yr. CAGR %	-8.82	-14.6	-2.92	9.05	10.08
Levered Free Cash Flow, 5 Yr. CAGR %	2.15	0.95	13.07	12.16	32.56
Unlevered Free Cash Flow, 5 Yr. CAGR %	3.75	1.74	12.32	12	27.73
Dividend Per Share, 5 Yr. CAGR %	-	14.87	0	0.7	2.71